Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

KIRA Uterine Drain Device Evaluation- First-In- Human Study

NCT: NCT07387380 · COMPLETED

NCT IDNCT07387380
StatusCOMPLETED
Start Date2026-01-06
Completion2026-04-05

Brief Summary

The purpose of this research is to evaluate a new investigational medical device, the Kira device, intended to make it easier for the surgical team to monitor blood loss during and immediately after cesarean deliveries (c-sections). This study will assess the safety of the device and the device's ability to gently suction blood from the uterus into a clear container where it can be seen and measured by the surgical team.

Frequently Asked Questions

What is KIRA Uterine Drain Device Evaluation- First-In- Human Study?

KIRA Uterine Drain Device Evaluation- First-In- Human Study is a clinical trial registered under NCT07387380. Current status: COMPLETED.

What is the status of NCT07387380?

The current status of NCT07387380 (KIRA Uterine Drain Device Evaluation- First-In- Human Study) is: COMPLETED.

When did KIRA Uterine Drain Device Evaluation- First-In- Human Study start?

KIRA Uterine Drain Device Evaluation- First-In- Human Study started on 2026-01-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.